» Articles » PMID: 21865131

Gastric Tumours in Hereditary Cancer Syndromes: Clinical Features, Molecular Biology and Strategies for Prevention

Overview
Specialty Oncology
Date 2011 Aug 26
PMID 21865131
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer is the major cause of cancer-related deaths worldwide. The majority of them are classified as sporadic, whereas the remaining 10% exhibit familial clustering. Hereditary diffuse gastric cancer (HDGC) syndrome is the most important condition that leads to hereditary gastric cancer. However, other hereditary cancer syndromes, such as hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, Peutz-Jeghers syndrome, Li-Fraumeni syndrome and hereditary breast and ovarian cancer, entail a higher risk compared to the general population for developing this kind of neoplasia. In this review, we describe briefly the most important aspects related to clinical features, molecular biology and strategies for prevention in hereditary gastric associated to different cancer syndromes.

Citing Articles

Confocal laser endomicroscopy as a new diagnostic tool for poorly differentiated gastric adenocarcinoma.

Evola G, Vacante M, Evola F World J Clin Cases. 2024; 12(26):5845-5849.

PMID: 39286386 PMC: 11287494. DOI: 10.12998/wjcc.v12.i26.5845.


Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.

Fernandez Acenero M, Diaz Del Arco C Curr Issues Mol Biol. 2024; 46(7):6440-6471.

PMID: 39057027 PMC: 11275188. DOI: 10.3390/cimb46070385.


Risk of Gastric Cancer is Highly Dependent on Type of First-Degree Family Member Affected by Cancer: Lessons from a High-Risk Population in Iran.

Abdi E, Latifi-Navid S, Zahri S, Mostafaiy B, Yazdanbod A, Pourfarzi F Iran J Public Health. 2023; 52(9):2004-2013.

PMID: 38033849 PMC: 10682579. DOI: 10.18502/ijph.v52i9.13582.


A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patients.

Zhang Y, Yang Y, Wei Q, Xu T, Zhang X, Gao J Gastroenterol Rep (Oxf). 2021; 9(4):339-349.

PMID: 34567566 PMC: 8460096. DOI: 10.1093/gastro/goab020.


Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21.

Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi A Cancer Sci. 2018; 109(12):4015-4024.

PMID: 30281874 PMC: 6272082. DOI: 10.1111/cas.13815.


References
1.
Domizio P, Talbot I, Spigelman A, Williams C, Phillips R . Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol. 1990; 43(9):738-43. PMC: 502752. DOI: 10.1136/jcp.43.9.738. View

2.
Gylling A, Abdel-Rahman W, Juhola M, Nuorva K, Hautala E, Jarvinen H . Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut. 2007; 56(7):926-33. PMC: 1994336. DOI: 10.1136/gut.2006.114876. View

3.
Petersen G, Slack J, Nakamura Y . Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology. 1991; 100(6):1658-64. DOI: 10.1016/0016-5085(91)90666-9. View

4.
Giardiello F, Hylind L, Trimbath J, Hamilton S, Romans K, Cruz-Correa M . Oral contraceptives and polyp regression in familial adenomatous polyposis. Gastroenterology. 2005; 128(4):1077-80. DOI: 10.1053/j.gastro.2004.10.010. View

5.
Caldas C, Carneiro F, Lynch H, Yokota J, Wiesner G, Powell S . Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999; 36(12):873-80. PMC: 1734270. View